206
Views
8
CrossRef citations to date
0
Altmetric
Articles: Brief Communications

Reversible pancytopenia following the consumption of decoction of Ganoderma neojaponicum Imazeki

, , , , &
Pages 115-117 | Received 28 Oct 2010, Accepted 07 Jan 2011, Published online: 03 Mar 2011

References

  • Sanodiya BS, Thakur GS, Baghel RK, Prasad GB, Bisen PS. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol 2009; 10:717–742.
  • Mizuno T, Wang G, Zhang J, Kawagishi H, Nishitoba T, Li J. Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev Int 1995; 11:151–166.
  • Zhang HN, Lin ZB. Hypoglycemic effect of Ganoderma lucidum polysaccharides. Acta Pharmacol Sin 2004; 25:191–195.
  • Yuen JW, Gohel MD. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer 2005; 53:11–17.
  • Brodsky RA, Jones RJ. Aplastic anemia. Lancet. 2005; 365:1647–1656.
  • Kojima S. Aplastic anemia in the Orient. Int J Hematol 2002; 76:173–174.
  • Aoki K, Ohtani M, Shimizu H. Epidemiological approach to the etiology of aplastic anemia. Aplastic anemia. In: Hibino S, Takaku F, Shahrdi NT, eds. Baltimore: University Park; 1978:155–170.
  • Pyatt DW, Yang Y, Mehos B, Le A, Stillman W, Irons RD. Hematotoxicity of the chinese herbal medicine Tripterygium wilfordii Hook F in CD34-positive human bone marrow cells. Mol Pharmacol 2000; 57:512–518.
  • Kyeon HM, Song WT, In KH, Kim JS. A case of reversible hypoplastic pancytopenia due to Ganoderma japonicum. Korean J Hematol 1991; 26:129–133.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.